EFdA, a reverse transcriptase inhibitor, potently blocks HIV-1 ex vivo infection of Langerhans cells within epithelium

J Invest Dermatol. 2014 Apr;134(4):1158-1161. doi: 10.1038/jid.2013.467. Epub 2013 Nov 11.

¹ Faculty of Medicine, Department of Dermatology, University of Yamanashi, Yamanashi, Japan.
² Faculty of Medicine, Department of Dermatology, University of Yamanashi, Yamanashi, Japan. Electronic address: tkawa@yamanashi.ac.jp.
³ Experimental Retrovirology Section, HIV and AIDS Malignancy Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
⁴ Department of Infectious Diseases and Hematology, Kumamoto University School of Medicine, Kumamoto, Japan.
⁵ Faculty of Medicine, Department of Microbiology, University of Yamanashi, Yamanashi, Japan.
⁶ Laboratory of Viral Pathogenesis, Institute for Virus Research, Kyoto University, Kyoto, Japan.
⁷ AIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan.
⁸ Experimental Retrovirology Section, HIV and AIDS Malignancy Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA; Department of Infectious Diseases and Hematology, Kumamoto University School of Medicine, Kumamoto, Japan.

No abstract available

Publication types